Featured Research

from universities, journals, and other organizations

HIV-positive children more likely to develop drug resistance

Date:
May 22, 2014
Source:
Tulane University
Summary:
74 percent of HIV-positive children in a study developed resistance to at least one form of drug treatment. The researchers followed almost 450 children enrolled in the Pediatric HIV/AIDS Cohort Study, one of the largest studies of HIV-positive children in the United States. "The problem with drug resistance is that once you develop it, it never goes away," said the principal investigator. "Some patients with very resistant virus have no effective treatment options. Resistant virus is the major reason for death among youth with perinatal HIV."

Study principal investigator Dr. Russell Van Dyke, professor of pediatric infectious diseases at Tulane University School of Medicine.
Credit: Paula Burch-Celentano, Tulane University

Children born with HIV are far more likely to develop resistance to antiretroviral drugs than adults, according to a new Tulane University School of Medicine study.

Related Articles


Researchers following almost 450 children enrolled in the Pediatric HIV/AIDS Cohort Study, one of the largest studies of HIV-positive children in the United States, found that 74 percent had developed resistance to at least one form of drug treatment and 30 percent were resistant to at least two classes of HIV treatment drugs. In comparison, nearly 36 percent of adults with HIV have resistance to one form of drug treatment and only 12 percent have resistance to at least two classes.

The study, which tracks patients at 14 sites across the country, followed participants from 7 to 16 years of age at enrollment.

"The problem with drug resistance is that once you develop it, it never goes away," said principal investigator Dr. Russell Van Dyke, professor of pediatric infectious diseases. "Some patients with very resistant virus have no effective treatment options. Resistant virus is the major reason for death among youth with perinatal HIV."

Fortunately, most adolescents with resistant HIV remain sensitive to newer agents from all classes, allowing salvage therapy. Just one child in the study had resistance to all HIV drugs and only 18 percent had resistance to one drug from each of the three primary classes of HIV medications.

The study emphasizes the importance of drug adherence for children and adolescents with HIV who typically take multiple medications daily to manage the disease. Once daily, single-pill HIV medications for adults are not yet available for children, Van Dyke said.

"The best way to prevent resistance from developing is to take your medicine and suppress your viral load," Van Dyke said. "You develop resistance when you take some of your medications but not all. Then you've got virus that is replicating in the face of taking your medication. Lack of adherence is the major reason resistance develops."

The study abstract was presented recently at the Conference on Retroviruses and Opportunistic Infections, and is available for viewing online at: http://croiconference.org/sites/all/abstracts/897.pdf


Story Source:

The above story is based on materials provided by Tulane University. The original article was written by Keith Brannon. Note: Materials may be edited for content and length.


Cite This Page:

Tulane University. "HIV-positive children more likely to develop drug resistance." ScienceDaily. ScienceDaily, 22 May 2014. <www.sciencedaily.com/releases/2014/05/140522123356.htm>.
Tulane University. (2014, May 22). HIV-positive children more likely to develop drug resistance. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2014/05/140522123356.htm
Tulane University. "HIV-positive children more likely to develop drug resistance." ScienceDaily. www.sciencedaily.com/releases/2014/05/140522123356.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins